AnalysisHealthNovember 20, 2026

Novartis CEO says AI could cut drug development from 12 years to eight

Read original source →bloomberg.com

Vasant Narasimhan, who also sits on Anthropic's board, said AI could shorten drug-development timelines from 12 years to eight and improve the odds of bringing new medicines to market. He spoke to Bloomberg's Francine Lacqua on "The Pulse."

People · Vasant Narasimhan

1 source

More stories today

Open the live feed